Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial

RCT (n=409) reports addition of maraviroc to standard combined ARV therapy does not improve clinical outcomes of patients initiating therapy for advanced HIV infection: during 72weeks follow up, first occurrence of severe morbidity 11.1 v 11.2/100 person-yrs respectively(HR 0.97)


Annals of Internal Medicine